Study protocol of the TIRED study: a randomised controlled trial comparing either graded exercise therapy for severe fatigue or cognitive behaviour therapy with usual care in patients with incurable cancer. Issue 1 (December 2017)

• Record Type: Journal Article
• Authors: Poort, Hanneke; Verhagen, Constans; Peters, Marlies; Goedendorp, Martine; Donders, A.; Hopman, Maria; Nijhuis-van der Sanden, Maria; Berends, Thea; Bleijenberg, Gijs; Knoop, Hans
• Is Part Of: BMC cancer. Volume 17:Issue 1(2017)
• Page Start: 1
• Page End: 12
• Publication Date: 2017-12
• Subjects: Fatigue -- Advanced cancer -- Graded exercise therapy -- Cognitive behaviour therapy -- Randomised controlled trial; Cancer -- Periodicals; 616.994005
• DOI: 10.1186/s12885-017-3076-0
• Languages: English
• ISSNs: 1471-2407

Abstract

Abstract Background Fatigue is a common and debilitating symptom for patients with incurable cancer receiving systemic treatment with palliative intent. There is evidence that non-pharmacological interventions such as graded exercise therapy (GET) or cognitive behaviour therapy (CBT) reduce cancer-related fatigue in disease-free cancer patients and in patients receiving treatment with curative intent. These interventions may also result in a reduction of fatigue in patients receiving treatment with palliative intent, by improving physical fitness (GET) or changing fatigue-related cognitions and behaviour (CBT). The primary aim of our study is to assess the efficacy of GET or CBT compared to usual care (UC) in reducing fatigue in patients with incurable cancer. Methods The TIRED study is a multicentre three-armed randomised controlled trial (RCT) for incurable cancer patients receiving systemic treatment with palliative intent. Participants will be randomised to GET, CBT, or UC. In addition to UC, the GET group will participate in a 12-week supervised exercise programme. The CBT group will receive a 12-week CBT intervention in addition to UC. Primary and secondary outcome measures will be assessed at baseline, post-intervention (14 weeks), and at follow-up assessments (18 and 26 weeks post-randomisation). The primary outcome measure is fatigue severity (Checklist Individual Strengthsubscale fatigue severity ). Secondary outcome measures are fatigue (EORTC-QLQ-C30subscale fatigue ), functional impairments (Sickness Impact Profiletotal score, EORTC-QLQ-C30subscale emotional functioning, subscale physical functioning ) and quality of life (EORTC-QLQ-C30subscale QoL ). Outcomes at 14 weeks (primary endpoint) of either treatment arm will be compared to those of UC participants. In addition, outcomes at 18 and 26 weeks (follow-up assessments) of either treatment arm will be compared to those of UC participants. Discussion To our knowledge, the TIRED study is the first RCT investigating the efficacy of GET and CBT on reducing fatigue during treatment with palliative intent in incurable cancer patients. The results of this study will provide information about the possibility and efficacy of GET and CBT for severely fatigued incurable cancer patients. Trial registration NTR3812 ; date of registration: 23/01/2013.